Florida Senate - 2023 SB 612 By Senator Yarborough 4-00814-23 2023612__ 1 A bill to be entitled 2 An act relating to the prevention of blood clots; 3 providing a short title; requiring the Agency for 4 Health Care Administration, in conjunction with the 5 Department of Health, to establish a blood clot and 6 pulmonary embolism prevention policy workgroup; 7 providing for membership, meetings, and duties of the 8 workgroup; requiring the agency to submit a certain 9 report to the Governor and the Legislature by a 10 specified date; requiring the agency to submit a final 11 report on the workgroup’s findings and recommendations 12 by a specified date; providing for expiration of the 13 workgroup; providing an effective date. 14 15 Be It Enacted by the Legislature of the State of Florida: 16 17 Section 1. This act may be cited as the “Emily Adkins Blood 18 Clot Prevention Act.” 19 Section 2. (1) The Agency for Health Care Administration, 20 in conjunction with the Department of Health, shall establish a 21 blood clot and pulmonary embolism prevention policy workgroup. 22 (2)(a) The workgroup shall be composed of the following 23 members: 24 1. Four members representing state-licensed health care 25 facilities, appointed by the Secretary of Health Care 26 Administration. 27 2. Four members representing state-licensed health care 28 providers, appointed by the State Surgeon General. The Surgeon 29 General shall select one of his or her appointees to serve as 30 chair of the workgroup. 31 3. Five members representing patients who have experienced 32 blood clots, family members of patients who have died from blood 33 clots, advocates for blood clot and pulmonary embolism 34 prevention policies, health care associations, and other 35 interested parties or associations, appointed by the Governor. 36 4. Two members appointed by the President of the Senate. 37 5. Two members appointed by the Speaker of the House of 38 Representatives. 39 (b) Members of the workgroup shall serve at their own 40 expense and are not entitled to receive compensation or 41 reimbursement for per diem or travel expenses. 42 (c) The workgroup shall meet at the call of the chair and 43 may conduct its meetings through teleconference or other 44 electronic means. 45 (d) The chair may create subcommittees to help with 46 gathering research, scheduling speakers on relevant subjects, 47 and drafting workgroup reports and policy recommendations. 48 (3) The workgroup shall do all of the following, at a 49 minimum: 50 (a) Identify the aggregate number of people who experience 51 blood clots and pulmonary embolisms each year in this state. 52 (b) Identify how data is collected in this state regarding 53 blood clots, pulmonary embolisms, and adverse health outcomes 54 associated with these conditions. 55 (c) Identify how blood clots and pulmonary embolisms impact 56 the lives of residents in this state. 57 (d) Identify the best practices and standards of care for 58 blood clot surveillance, detection, and treatment. 59 (e) Identify emerging treatments, therapies, and research 60 relating to blood clots and pulmonary embolisms. 61 (f) Develop a risk surveillance system to help health care 62 providers identify patients who may be at higher risk for blood 63 clots or pulmonary embolisms. 64 (g) Develop policy recommendations to help improve patient 65 awareness of blood clot risks. 66 (h) Develop policy recommendations to help health care 67 facilities, including, but not limited to, hospitals, ambulatory 68 surgical centers, nursing homes, assisted living facilities, and 69 residential treatment facilities, improve surveillance and 70 detection of patients who may be at a higher risk for blood 71 clots or pulmonary embolisms. 72 (i) Develop recommended guidelines for the standard of care 73 for patients at risk for blood clots or pulmonary embolisms. 74 (j) Develop recommended literature relating to increased 75 risks of blood clots which health care facilities and health 76 care providers can provide to patients and their families. 77 (4) By January 31, 2024, the Agency for Health Care 78 Administration shall submit a report to the Governor, the 79 President of the Senate, and the Speaker of the House of 80 Representatives which provides an update on the workgroup’s 81 activities, findings, and recommendations. The agency shall 82 submit a final report on all of the workgroup’s findings and 83 recommendations by January 31, 2025. 84 (5) This section expires February 1, 2025. 85 Section 3. This act shall take effect upon becoming a law.